Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome Following Truncation of Asparaginase in the NOPHO ALL2008 Protocol

NCT03987542 is registered in ClinicalTrials.gov with Birgitte Klug Albertsen as lead sponsor.

NCT NCT03987542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03987542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome Following Truncation of Asparaginase in the NOPHO ALL2008 Protocol
Lead sponsor
Birgitte Klug Albertsen
Phase
Observational
Overall status
Completed
Start date
July 31, 2008
Completion date
June 30, 2020
Enrollment
1,401 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapse leukemia